Study Type
Observational - Registry
completed
This heart failure (HF) registry in Africa, Asia and South America will gather information on the current status of HF etiology, treatment, potential barriers to evidence-based care, and outcome in these rapidly developing regions of the world.
The collected information will help fill in important gaps in the understanding of HF globally.
Primary endpoint:
All-cause mortality at one year.
The Principal Investigator of the INTER-CHF study was Hisham Dokainish, then Professor, Division of Cardiology, Department of Medicine, McMaster University.
Study Design
A prospective, international, multicenter cross-sectional study, including a longitudinal component
NO. of Countries
16
NO. of Sites
108
NO. of Participants
5823
Study Period
2012-2015
Sponsor
PHRI
Tara McCready
Program Director
Tara McCready
Program Director
Tara McCready, PhD, oversees a variety of collaborative programs at PHRI, and serves as Project Manager for PHRI research studies and registries.
She was recruited to PHRI as a Program Director for the Canadian Network and Centre for Trials Internationally (CANNeCTIN), a national network funded by the CIHR/CFI Clinical Research Initiative program to improve the prevention and treatment of cardiac and vascular diseases and diabetes.
Previously the Executive Director of the Canadian Maternal, Infant, Child and Youth Research Network, Tara holds a PhD in Biochemistry and a MBA in Technology Commercialization from the University of Alberta.
Alex Grinvalds
Project Manager
Alex Grinvalds
Project Manager
Alex Grinvalds has more than 15 years experience in clinical research, of which 13 have been at PHRI. He has worked on randomized studies, device trials and numerous registries. Currently, Alex is working on studies involving patients with heart failure and arrhythmias.
Alex holds a Bachelor of Science degree from Queen’s University and a Certificate in Clinical Research from Humber College.
ongoing
G-CHF
Arrhythmia & Heart Failure
Heart failure (HF) is a rapidly increasing disease worldwide but there is no global HF...
